Patient-Specific 3-Dimensional Model of Smooth Muscle Cell and Extracellular Matrix Dysfunction for the Study of Aortic Aneurysms.


Journal

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
ISSN: 1545-1550
Titre abrégé: J Endovasc Ther
Pays: United States
ID NLM: 100896915

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 28 4 2021
medline: 27 7 2021
entrez: 27 4 2021
Statut: ppublish

Résumé

Abdominal aortic aneurysms (AAAs) are associated with overall high mortality in case of rupture. Since the pathophysiology is unclear, no adequate pharmacological therapy exists. Smooth muscle cells (SMCs) dysfunction and extracellular matrix (ECM) degradation have been proposed as underlying causes. We investigated SMC spatial organization and SMC-ECM interactions in our novel 3-dimensional (3D) vascular model. We validated our model for future use by comparing it to existing 2-dimensional (2D) cell culture. Our model can be used for translational studies of SMC and their role in AAA pathophysiology. SMC isolated from the medial layer of were the aortic wall of controls and AAA patients seeded on electrospun poly-lactide- We show that cultured SMC proliferate into multiple layers after 5 weeks in culture and produce ECM proteins, mimicking their behavior in the medial aortic layer. EC attach to multilayered SMC, mimicking layer interactions. The novel SMC model exhibits viscoelastic properties comparable to biological vessels; cytoskeletal organization increases during the 5 weeks in culture; increased cytoskeletal alignment and decreased ECM production indicate different organization of AAA patients' cells compared with control. We present a valuable preclinical model of AAA constructed with patient specific cells with applications in both translational research and therapeutic developments. We observed SMC spatial reorganization in a time course of 5 weeks in our robust, patient-specific model of SMC-EC organization and ECM production.

Identifiants

pubmed: 33902345
doi: 10.1177/15266028211009272
pmc: PMC8276336
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

604-613

Références

Materials (Basel). 2017 Aug 02;10(8):
pubmed: 28767075
Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):26-34
pubmed: 27879251
Circulation. 1996 Dec 1;94(11):2708-11
pubmed: 8941093
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nanotechnology. 2010 Nov 5;21(44):445101
pubmed: 20921592
Biomaterials. 2007 Feb;28(6):1115-22
pubmed: 17112581
J Mech Behav Biomed Mater. 2015 Oct;50:150-9
pubmed: 26143307
Annu Rev Genomics Hum Genet. 2008;9:283-302
pubmed: 18544034
Eur Heart J Cardiovasc Imaging. 2019 Feb 1;20(2):185-191
pubmed: 29618036
Exp Cell Res. 2004 Jul 15;297(2):574-84
pubmed: 15212957
Eur J Vasc Endovasc Surg. 2020 Mar;59(3):494
pubmed: 31839474
Mater Today (Kidlington). 2011 Mar;14(3):96-105
pubmed: 22723736
Biomaterials. 2006 Jul;27(19):3608-16
pubmed: 16530824
Pathol Biol (Paris). 2001 May;49(4):326-32
pubmed: 11428168
Circ Res. 2015 Apr 10;116(8):1448-61
pubmed: 25858068
Int J Cardiol. 2013 May 10;165(2):314-21
pubmed: 21937134
Biomed Pharmacother. 2003 Jul-Aug;57(5-6):195-202
pubmed: 12888254
Cardiovasc Revasc Med. 2018 Dec;19(8):956-959
pubmed: 30097189
Eur J Vasc Surg. 1993 Nov;7(6):633-7
pubmed: 8270064
Lancet. 2005 Apr 30-May 6;365(9470):1577-89
pubmed: 15866312
Postgrad Med J. 2009 May;85(1003):268-73
pubmed: 19520879
Mol Biol Cell. 2011 Oct;22(20):3791-800
pubmed: 21865599
Nat Protoc. 2014 Feb;9(2):457-63
pubmed: 24481272
Biomed Mater. 2017 Oct 05;12(6):065006
pubmed: 28714856
Polymers (Basel). 2011 Sep 1;3(3):1377-1397
pubmed: 22577513
Sci Rep. 2019 May 2;9(1):6837
pubmed: 31048749
PLoS One. 2018 Jan 26;13(1):e0191919
pubmed: 29373598
Hum Mutat. 2009 Oct;30(10):1406-11
pubmed: 19639654
Curr Eye Res. 2018 Jan;43(1):1-11
pubmed: 29281419

Auteurs

Natalija Bogunovic (N)

Amsterdam Cardiovascular Sciences, Department of Vascular Surgery, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.
Amsterdam Cardiovascular Sciences, Department of Physiology, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.
Amsterdam Cardiovascular Sciences, Department of Clinical Genetics, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.

Jorn P Meekel (JP)

Amsterdam Cardiovascular Sciences, Department of Vascular Surgery, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.
Amsterdam Cardiovascular Sciences, Department of Physiology, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.

Jisca Majolée (J)

Amsterdam Cardiovascular Sciences, Department of Physiology, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.

Marije Hekhuis (M)

Amsterdam Cardiovascular Sciences, Department of Clinical Genetics, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.

Jakob Pyszkowski (J)

Optics11 BV, Amsterdam, The Netherlands.

Stefan Jockenhövel (S)

Aachen-Maastricht Institute for Biobased Materials, Faculty of Science and Engineering, Maastricht University, Geleen, The Netherlands.
Department of Biohybrid & Medical Textiles (Biotex), RWTH Aachen University, Aachen, Germany.

Magnus Kruse (M)

Department of Biohybrid & Medical Textiles (Biotex), RWTH Aachen University, Aachen, Germany.
Institut für Textiltechnik der RWTH Aachen University, Aachen, Germany.

Elise Riesebos (E)

Amsterdam Cardiovascular Sciences, Department of Clinical Genetics, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.

Dimitra Micha (D)

Amsterdam Cardiovascular Sciences, Department of Clinical Genetics, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.

Jan D Blankensteijn (JD)

Amsterdam Cardiovascular Sciences, Department of Vascular Surgery, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.

Peter L Hordijk (PL)

Amsterdam Cardiovascular Sciences, Department of Physiology, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.

Samaneh Ghazanfari (S)

Aachen-Maastricht Institute for Biobased Materials, Faculty of Science and Engineering, Maastricht University, Geleen, The Netherlands.
Department of Biohybrid & Medical Textiles (Biotex), RWTH Aachen University, Aachen, Germany.

Kak K Yeung (KK)

Amsterdam Cardiovascular Sciences, Department of Vascular Surgery, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.
Amsterdam Cardiovascular Sciences, Department of Physiology, Amsterdam University Medical Centers, Location VUmc, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH